APOTHEEK SOMERS

Active

Private limited companyfounded 2012active for 13 yearsJean-Baptiste Depairelaan 179, 1090 Jette, BelgiumKBO/BCE: BE 0508.693.932

From the official registers: KBO 13 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

APOTHEEK SOMERS has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €67,449 and a net result of €61,360. Equity is growing by about 6% per year across the filed financial years. Its solvency ranks better than 29% of 12,737 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Risk analysisFollow Report Compare

APOTHEEK SOMERSActiveChecked score 85/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 24-12-2012 Normal situation
Legal form: Private limited company
Registered office: Jean-Baptiste Depairelaan 179, 1090 Jette
Activity: Retail sale of pharmaceutical products NACE 47730
Establishment unit: 2.215.953.122 1090 Jette, since 01-01-2013
Financial year end: 31 December
Peppol: Reachable since 08-01-2026

Company details

Who decides

Board

Jonckheere-Somers BVDirector · since 30-03-2016

Shareholders

JONCKHEERE-SOMERS100%annual accounts 2025

Board & ownership

How it is doing

85 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.4%

Annual accounts 2025

Gross margin: €86,418; ▲ 0.9%
Turnover: ≈ €420,000; estimated
Profit: €61,360; ▲ 1.8%
Equity: €67,449; ▲ 3.6%
Total assets: €369,753; ▼ 1.9%

2025 accounts filed 5 days late

Filed on 05-08-2026at the National Bank

Financials

Why 85raises riskLast filed accounts filed 5 days late; 1 of the last 3 lateSector: Retail trade (NACE 47)Equity €67,449 (18.2% of total assets)lowers riskFounded in 2012Show the evidence

Checked score

Score 2025

85 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 59% of its sector peers (NACE 47, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 43+1

equity 18.2% of total assets

Liquidity 62-2

short-term debt 71.2% · cash 44.3%

Profitability 89=

return on assets 16.6%

Bankruptcy probability, 12 months

0.4% Very low

0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)

Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024lowest value 02-2025: 0.2%● unchanged vs 01-2025lowest value 03-2025: 0.2%● unchanged vs 02-2025lowest value 04-2025: 0.3%▲ +0.1 percentage points vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.3%● unchanged vs 06-2025 08-2025: 0.5%▲ +0.2 percentage points vs 07-2025 09-2025: 0.7%▲ +0.2 percentage points vs 08-2025 10-2025: 0.4%▼ -0.3 percentage points vs 09-2025 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.4%● unchanged vs 12-2025 02-2026: 0.4%● unchanged vs 01-2026 03-2026: 0.4%● unchanged vs 02-2026 04-2026: 0.4%● unchanged vs 03-2026 05-2026: 0.4%● unchanged vs 04-2026 06-2026: 0.4%● unchanged vs 05-2026 07-2026: 0.4%● unchanged vs 06-2026 08-2026: 0.7%▲ +0.3 percentage points vs 07-2026highest value 09-2026: 0.4%▼ -0.3 percentage points vs 08-2026 10-2026: 0.4%● unchanged vs 09-2026

Credit of up to €5,000 on 30-day terms is acceptable

Liquidity tight (current ratio 1.26, compared with 1.27 in 2024, below the usual 1.5; short-term debt: 71.2% and cash: 44.3% of total assets), and 81.8% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 34% on solvency, 68% on liquidity, 84% on profitability and 49% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises risk

Last filed accounts filed 5 days late; 1 of the last 3 late

NBB · filings

Founded in 2012

Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.

KBO

Sector: Retail trade (NACE 47)

KBO

Equity €67,449 (18.2% of total assets)

NBB · annual accounts

2025 accounts filed 5 days late

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-08-2026, 5 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.

NBB · 10 filings

Deviation from the deadline

2025

5 days late

2024

35 days late

2023

22 days late

2022

9 days early

2021

12 days late

2020

20 days late

2019

3 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 13 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 12 August (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Positive: 6 profitable years in a rowprofit 2025: €61,360 6 years View

Documents

Key facts about APOTHEEK SOMERS

What is the company number of APOTHEEK SOMERS?: 0508.693.932. In Belgium the VAT number is the company number with BE in front: BE 0508.693.932.
Where is APOTHEEK SOMERS based?: The registered office is at Jean-Baptiste Depairelaan 179, 1090 Jette.Company details
What does APOTHEEK SOMERS do?: According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK SOMERS?: Private limited company (BV).
When was APOTHEEK SOMERS founded?: On 24-12-2012.
Is APOTHEEK SOMERS still active?: Yes, APOTHEEK SOMERS is an active enterprise in the KBO register.
What is the turnover of APOTHEEK SOMERS?: ≈ €420,000 in financial year 2025. Estimated from the gross margin of €86,418: probably between €210,000 and €610,000, based on 73 comparable companies, NACE 477.Financials
Is APOTHEEK SOMERS profitable?: In financial year 2025, APOTHEEK SOMERS made a profit of €61,360.
Where can I find the annual accounts of APOTHEEK SOMERS?: APOTHEEK SOMERS filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of APOTHEEK SOMERS due?: By 31-07-2027, for financial year 2026.Timeline